Instead, we demonstrated the suppression of other microglial mobility/phagocytosis-associated genes such as Icam2, Acta2, Fos, Fosb, Egr1, Lamb2 and Tpm2 in both synucleinopathy patients and the animal model (Figs. 4 and 8). This evidence concerns the gene ACTA2 and synucleinopathy.